Rivastigmine Tartrate
- Product NDC
- 70518-3012
- 11-digit product format
- 705183012
- Labeler code
- 70518
- Product ID
- 70518-3012_ba7054d5-b16a-8373-e053-2995a90a2470
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rivastigmine Tartrate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA204572
- Marketing category
- ANDA
- Marketing start
- 2021-02-02
- Marketing end
- 0000-00-00
- Substance
- RIVASTIGMINE TARTRATE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-3012-0 | 70518301200 | 30 POUCH in 1 BOX (70518-3012-0) > 1 CAPSULE in 1 POUCH (70518-3012-1) | 30 pouch | 2021-02-02 | 0000-00-00 | No | No | Current |